Chelouah S, Cochet E, Couve S, Balkaran S, Robert A, May E
Cancers (Basel). 2018; 10(1).
PMID: 29303964
PMC: 5789362.
DOI: 10.3390/cancers10010012.
Wakeman B, Izumiya Y, Speck S
J Virol. 2016; 91(1).
PMID: 27795414
PMC: 5165194.
DOI: 10.1128/JVI.01434-16.
Wakeman B, Johnson L, Paden C, Gray K, Virgin H, Speck S
J Virol. 2014; 88(10):5474-90.
PMID: 24574412
PMC: 4019092.
DOI: 10.1128/JVI.03110-13.
Tierney R, Kao K, Nagra J, Rickinson A
J Virol. 2011; 85(23):12362-75.
PMID: 21957300
PMC: 3209410.
DOI: 10.1128/JVI.06059-11.
Hughes D, Dickerson C, Shaner M, Sample C, Sample J
J Virol. 2011; 85(21):11435-47.
PMID: 21865378
PMC: 3194970.
DOI: 10.1128/JVI.05158-11.
C-terminal region of EBNA-2 determines the superior transforming ability of type 1 Epstein-Barr virus by enhanced gene regulation of LMP-1 and CXCR7.
Cancian L, Bosshard R, Lucchesi W, Elgueta Karstegl C, Farrell P
PLoS Pathog. 2011; 7(7):e1002164.
PMID: 21857817
PMC: 3145799.
DOI: 10.1371/journal.ppat.1002164.
Viral latency and its regulation: lessons from the gamma-herpesviruses.
Speck S, Ganem D
Cell Host Microbe. 2010; 8(1):100-15.
PMID: 20638646
PMC: 2914632.
DOI: 10.1016/j.chom.2010.06.014.
Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.
Rowe M, Kelly G, Bell A, Rickinson A
Semin Cancer Biol. 2009; 19(6):377-88.
PMID: 19619657
PMC: 3764430.
DOI: 10.1016/j.semcancer.2009.07.004.
Nuclear-cytoplasmic shuttling is not required for the Epstein-Barr virus EBNA-LP transcriptional coactivation function.
Ling P, Tan J, Peng R
J Virol. 2009; 83(14):7109-16.
PMID: 19403674
PMC: 2704764.
DOI: 10.1128/JVI.00654-09.
Regulation of Sp100A subnuclear localization and transcriptional function by EBNA-LP and interferon.
Echendu C, Ling P
J Interferon Cytokine Res. 2008; 28(11):667-78.
PMID: 18844582
PMC: 2988464.
DOI: 10.1089/jir.2008.0023.
Epstein-Barr virus exploits BSAP/Pax5 to achieve the B-cell specificity of its growth-transforming program.
Tierney R, Nagra J, Hutchings I, Shannon-Lowe C, Altmann M, Hammerschmidt W
J Virol. 2007; 81(18):10092-100.
PMID: 17626071
PMC: 2045388.
DOI: 10.1128/JVI.00358-07.
Truncated form of the Epstein-Barr virus protein EBNA-LP protects against caspase-dependent apoptosis by inhibiting protein phosphatase 2A.
Garibal J, Hollville E, Bell A, Kelly G, Renouf B, Kawaguchi Y
J Virol. 2007; 81(14):7598-607.
PMID: 17494066
PMC: 1933342.
DOI: 10.1128/JVI.02435-06.
Identification of spliced gammaherpesvirus 68 LANA and v-cyclin transcripts and analysis of their expression in vivo during latent infection.
Allen 3rd R, Dickerson S, Speck S
J Virol. 2006; 80(4):2055-62.
PMID: 16439562
PMC: 1367133.
DOI: 10.1128/JVI.80.4.2055-2062.2006.
Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100.
Ling P, Peng R, Nakajima A, Yu J, Tan J, Moses S
EMBO J. 2005; 24(20):3565-75.
PMID: 16177824
PMC: 1276704.
DOI: 10.1038/sj.emboj.7600820.
The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter.
Peng R, Moses S, Tan J, Kremmer E, Ling P
J Virol. 2005; 79(7):4492-505.
PMID: 15767449
PMC: 1061541.
DOI: 10.1128/JVI.79.7.4492-4505.2005.
Complete genomic sequence of an Epstein-Barr virus-related herpesvirus naturally infecting a new world primate: a defining point in the evolution of oncogenic lymphocryptoviruses.
Rivailler P, Cho Y, Wang F
J Virol. 2002; 76(23):12055-68.
PMID: 12414947
PMC: 136909.
DOI: 10.1128/jvi.76.23.12055-12068.2002.
Molecular virology of Epstein-Barr virus.
Bornkamm G, Hammerschmidt W
Philos Trans R Soc Lond B Biol Sci. 2001; 356(1408):437-59.
PMID: 11313004
PMC: 1088437.
DOI: 10.1098/rstb.2000.0781.
Conserved regions in the Epstein-Barr virus leader protein define distinct domains required for nuclear localization and transcriptional cooperation with EBNA2.
Peng R, Tan J, Ling P
J Virol. 2000; 74(21):9953-63.
PMID: 11024123
PMC: 102033.
DOI: 10.1128/jvi.74.21.9953-9963.2000.
Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses.
Peng R, Gordadze A, Fuentes Panana E, Wang F, Zong J, Hayward G
J Virol. 1999; 74(1):379-89.
PMID: 10590127
PMC: 111549.
DOI: 10.1128/jvi.74.1.379-389.2000.
B-cell lines immortalized with an Epstein-Barr virus mutant lacking the Cp EBNA2 enhancer are biased toward utilization of the oriP-proximal EBNA gene promoter Wp1.
Yoo L, Mooney M, Puglielli M, Speck S
J Virol. 1997; 71(12):9134-42.
PMID: 9371570
PMC: 230214.
DOI: 10.1128/JVI.71.12.9134-9142.1997.